RIVASTIGMINE TARTRATE | A203844 | CADILA PHARMACEUTICALS LTD
Highest NADAC/Unit
$0.2058
per ea
Lowest NADAC/Unit
$0.1542
per ea
Brand NDCs
0
Generic NDCs
4
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 72241001303RIVASTIGMINE 4.5 MG CAPSULE | $0.2058 | EA | Generic | — | 2026-06-17 |
| 72241001203RIVASTIGMINE 3 MG CAPSULE | $0.1666 | EA | Generic | — | 2026-06-17 |
| 72241001403RIVASTIGMINE 6 MG CAPSULE | $0.1638 | EA | Generic | — | 2026-06-17 |
| 72241001103RIVASTIGMINE 1.5 MG CAPSULE | $0.1542 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.